A study of paraoxonase1 (PON1) activities, HDL cholesterol and its association with vascular complication in type 2 diabetes mellitus

Mogarekar, Mukund; Dhabe, Mahendra; Gujrathi, Chanchal
December 2016
International Journal of Diabetes in Developing Countries;Dec2016, Vol. 36 Issue 4, p457
Academic Journal
The article aims to find clinical relevance of estimating serum paraoxonase1 (PON1) arylesterase and PON1 lactonase activity and its association with cardiovascular complications in patients with type 2 diabetes mellitus. It discusses the association of PON gene with high density lipoprotein (HDL) cholesterol and indicates the development of vascular complications in type 2 DM patients.


Related Articles

  • ‘Prosiect Sir Gâr’: workplace-based cardiovascular disease and diabetes risk assessments. Gray, B. J.; Bracken, R. M.; Thomas, M.; Williams, S. P.; Williams, M.; Rice, S.; Stephens, J. W. // Occupational Medicine;Oct2014, Vol. 64 Issue 7, p549 

    Background Cardiovascular disease (CVD) and diabetes remain two of the greatest health challenges in the UK. Government guidelines recommend screening for both of these conditions to identify individuals at high risk. Assessing individuals in the work environment for these two conditions as part...

  • Gene for HDL-linked protein associated with CVD risk. Raible, Eric // Cardiology Today;May2008, Vol. 11 Issue 5, p36 

    The article discusses research being done on the association between a gene responsible for the high-density lipoprotein (HDL)-associated protein paraoxonase 1 and systemic oxidative stress and cardiovascular risk. It references a study by Stanley L. Hazen and colleagues, published in a 2008...

  • Correlation between several extrinsic factors and Paraoxonase 1 activities. Ciumărnean, Lorena; Dronca, Eleonora; Coadă, Camelia A.; Sâmpelean, Dorel P.; Achimaş-Cadariu, Andrei // Human & Veterinary Medicine;2013, Vol. 5 Issue 3, p88 

    Objective: to investigate the PON1 activity (aryl esterase, paraoxonase and lactonase) as well as the possible influence of non-genetic factors in a representative cohort of patients with steatosis. Material and methods: We enrolled 39 subjects with steatosis that were hospitalised for...

  • The Association of Sex Hormone and the Metabolic Syndrome in Healthy Korean Males. Eun-Jung Rhee; Se-Yeon Kim; Chan-Hee Jung; Cheol Young Park; Won-Young Lee; Ki-Won Oh; Sung-Woo Park; Sun-Woo Kim // Diabetes;Jun2007 Supplement 1, Vol. 56, pA340 

    Background: Metabolic syndrome is a strong risk factor for type 2 diabetes mellitus and cardiovascular disease and its prevalence is markedly increasing. Recent studies report the association of androgen deficiency with the development of metabolic syndrome. We analyzed the association of serum...

  • First-line treatment patterns and lipid target levels attainment in very high cardiovascular risk outpatients. Xanthopoulou, Ioanna; Davlouros, Periklis; Siahos, Simos; Perperis, Angelos; Evangelia, Zaharioglou; Alexopoulos, Dimitrios // Lipids in Health & Disease;2013, Vol. 12 Issue 1, p1 

    Objectives Previous studies have demonstrated gaps in achievement of low-density lipoproteincholesterol (LDL-C) goals among patients at very high cardiovascular risk. We aimed to investigate lipid treatment patterns, rates and predictors of lipid targets attainment, in such outpatients in an...

  • Effect of White Wine Consumption on Oxidative Stress Markers and Homocysteine Levels. Rajdl, D.; Racek, J.; Trefil, L.; Siala, K. // Physiological Research;2007, Vol. 56 Issue 2, p203 

    The aim of this study was to assess the influence of regular daily consumption of white wine on oxidative stress and cardiovascular risk markers. Forty-two healthy male volunteers consumed 375 ml of white wine daily. Each participant provided three venous blood samples (before wine consumption,...

  • Novel Associations of Nonstructural Loci with Paraoxonase Activity. Quillen, Ellen E.; Rainwater, David L.; Dyer, Thomas D.; Carless, Melanie A.; Curran, Joanne E.; Johnson, Matthew P.; Göring, Harald H. H.; Cole, Shelley A.; Rutherford, Sue; MacCluer, Jean W.; Moses, Eric K.; Blangero, John; Almasy, Laura; Mahaney, Michael C. // Journal of Lipids;2012, p1 

    The high-density-lipoprotein-(HDL-) associated esterase paraoxonase 1 (PON1) is a likely contributor to the antioxidant and antiatherosclerotic capabilities of HDL. Two nonsynonymous mutations in the structural gene, PON1, have been associated with variation in activity levels, but substantial...

  • Solubilization and Humanization of Paraoxonase-1. Sarkar, Mohosin; Harsch, Christina Keventzidis; Matic, George T.; Hoffman, Kathryn; Norris, Joseph R.; Otto, Tamara C.; Lenz, David E.; Cerasoli, Douglas M.; Magliery, Thomas J. // Journal of Lipids;2012, p1 

    Paraoxonase-1 (PON1) is a serum protein, the activity of which is related to susceptibility to cardiovascular disease and intoxication by organophosphorus (OP) compounds. It may also be involved in innate immunity, and it is a possible lead molecule in the development of a catalytic bioscavenger...

  • Anti-Psoriatic Therapy Recovers High-Density Lipoprotein Composition and Function. Holzer, Michael; Wolf, Peter; Inzinger, Martin; Trieb, Markus; Curcic, Sanja; Pasterk, Lisa; Weger, Wolfgang; Heinemann, Akos; Marsche, Gunther // Journal of Investigative Dermatology;Mar2014, Vol. 134 Issue 3, p635 

    Psoriasis is a chronic inflammatory disorder associated with increased cardiovascular mortality. Psoriasis affects high-density lipoprotein (HDL) composition, generating dysfunctional HDL particles. However, data regarding the impact of anti-psoriatic therapy on HDL composition and function are...

  • Serum Paraoxonase (Arylesterase) Activity in Chronic Renal Failure. Gayathri, Balasubramaniam; Usha, Anand; Vijaya, Duraisamy // Journal of Medicine;Jan2011, Vol. 12 Issue 1, p17 

    Background: Mortality rates are higher among patients with chronic renal failure with a good proportion of this excess burden being attributable to cardiovascular disease. This excess risk is not entirely explained by elevated traditional risk factors. Among the non-traditional risk factors,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics